English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jun 3, 2026

Biotech leaders discuss U.S.-China competition and AI's role in industry innovation
+ Pharmaceuticals
Patient Daily | Jun 3, 2026

FDA accepts BridgeBio application for priority review of muscular dystrophy drug BBP-418
+ Pharmaceuticals
Patient Daily | Jun 2, 2026

Merck’s TROP2 strategy draws attention at ASCO as Keytruda faces future competition
+ Pharmaceuticals
Patient Daily | Jun 2, 2026

Moderna and Merck report improved survival with mRNA melanoma vaccine at ASCO meeting
+ Pharmaceuticals
Patient Daily | Jun 2, 2026

FDA advisory committee to review Moderna mRNA flu vaccine in June
+ Pharmaceuticals
Patient Daily | Jun 2, 2026

Pfizer presents new cancer drug data at ASCO, with key results still pending
+ Pharmaceuticals
Patient Daily | Jun 1, 2026

FARE to lead national conversation on food allergy at Menus of Change Summit
+ Pharmaceuticals
Patient Daily | Jun 1, 2026

Immuneering’s pancreatic cancer drug shows extended survival in Phase 2a trial

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes